Skyhawk Therapeutics | Finanzwire

Basculer en Français

9952	Companies
201486	Keywords
132145	Articles
107012	Press releases

Home
Companies
Skyhawk Therapeutics

BRIEF

published on 03/02/2026 at 16:40, 3 hours 44 minutes ago

Skyhawk's SKY-0515 Secures TGA Provisional Approval Eligibility for Huntington's Treatment

Huntington's Disease Skyhawk Therapeutics SKY-0515 Therapeutic Goods Administration Provisional Approval
PRESS RELEASE

published on 03/02/2026 at 16:35, 3 hours 49 minutes ago

Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Skyhawk Therapeutics announces that Australia's Therapeutic Goods Administration has determined SKY-0515 for Huntington's Disease meets eligibility criteria for provisional registration pathway

Australia Huntington's Disease Skyhawk Therapeutics SKY-0515 Therapeutic Goods Administration
BRIEF

published on 01/27/2026 at 14:10, 1 month 6 days ago

Skyhawk Therapeutics Reports Interim Phase 1 Results for Huntington's Treatment SKY-0515

Phase 1 Clinical Trial Interim Results Huntington's Disease Skyhawk Therapeutics SKY-0515
PRESS RELEASE

published on 01/27/2026 at 14:05, 1 month 6 days ago

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics reports positive interim results in Phase 1 Clinical Trial of SKY-0515 for Huntington's Disease, showing promising data on disease progression and safety

Biotechnology Clinical Trial Huntington's Disease Skyhawk Therapeutics SKY-0515

Accesswire

Published on 03/02/2026 at 18:35, 1 hour 49 minutes ago

Electrovaya Announces Results of Annual Meeting of Shareholders
Published on 03/02/2026 at 17:40, 2 hours 44 minutes ago

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
Published on 03/02/2026 at 16:35, 3 hours 49 minutes ago

Copper Road Announces $650,000 Financing
Published on 03/02/2026 at 16:00, 4 hours 24 minutes ago

MWC 2026: Amdocs Announces Research Collaboration with Stanford Researchers to Study AI's Impact on Software Engineering Productivity
Published on 03/02/2026 at 15:22, 5 hours 2 minutes ago

Silver Spruce Resources Inc. Announces Non-Brokered Private Placement for Proceeds of up to $2,000,000

View all ACCESSWIRE

EQS Group

Published on 03/02/2026 at 19:50, 34 minutes ago

EQS-Adhoc: Beiersdorf Aktiengesellschaft: Guidance 2026 –– New Share Buyback Program
Published on 03/02/2026 at 19:36, 48 minutes ago

POS-Transaction in Own Shares
Published on 03/02/2026 at 19:07, 1 hour 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/02/2026 at 18:30, 1 hour 54 minutes ago

United States (U.S.) Secretary of Energy Chris Wright is back to Powering Africa Summit 2026 to discuss energy access and clean cooking
Published on 03/02/2026 at 18:05, 2 hours 19 minutes ago

Huawei Cloud Summit at MWC26: Solving Industry Challenges with AI

Les Echos

Published on 03/02/2026 at 18:00, 2 hours 24 minutes ago

THERMADOR GROUPE : Annual results 2025
Published on 03/02/2026 at 17:35, 2 hours 49 minutes ago

Disclosure of transactions in own shares from February 23 to February 27, 2026
Published on 03/02/2026 at 08:45, 11 hours 39 minutes ago

Imerys: 2025 consolidated financial statements
Published on 02/27/2026 at 23:00, 2 days 21 hours ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 3 days 2 hours ago

AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion

View all LES ECHOS COMFI WIRE